The current earnings forecast score of Alcon AG is 8.11, ranking 67 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 95.85, with a high of 112.00 and a low of 80.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
87.870
Target Price
+26.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Alcon AG
ALC
17
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Alcon AG's expected revenue for the next quarter?
Alcon AG's expected revenue is 2.76B.
What is Alcon AG's price target?
Analysts forecast that Alcon AG's price target is USD 95.85, with the highest forecast at USD 112.00 and the lowest forecast at USD 80.00.
How have Alcon AGALC's recent earnings per share performed?
The market expectation was USD 0.39, while Alcon AGALC's earnings per share (EPS) for the previous quarter was USD 0.44. EPS for the next quarter is expected at USD 0.76.
What is the analyst rating for Alcon AG?
Based on the ratings of Alcon AG's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.